FinalDose

FinalDose is a company focused on developing a comprehensive architecture for cancer therapy. Their approach is built on three key pillars: DNA, programmability, and elimination. By leveraging the information encoded in DNA, they aim to pinpoint the specific address of cancer cells, which is essential for targeted treatment. The concept of programmability suggests that their solutions can be scaled effectively, allowing for adaptable therapies that can respond to varying patient needs. Finally, the elimination aspect highlights their goal of curing cancer through innovative and precise methods…